173 related articles for article (PubMed ID: 36155259)
61. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
[TBL] [Abstract][Full Text] [Related]
62. Prognostic and predictive significance of GITR in metastatic renal cell carcinoma.
Balçık OY; Akın D; Ceylan GS; Demİr B; Aytaç A; Çulhacı N; Oktay E
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7781-7792. PubMed ID: 37667956
[TBL] [Abstract][Full Text] [Related]
63. [GITR/GITRL expression in peripheral blood of rheumatoid arthritis].
Liu YY; Chang LL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 39(2):163-6. PubMed ID: 17440592
[TBL] [Abstract][Full Text] [Related]
64. Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivo.
van der Werf N; Redpath SA; Phythian-Adams AT; Azuma M; Allen JE; Maizels RM; Macdonald AS; Taylor MD
J Immunol; 2011 Aug; 187(3):1411-20. PubMed ID: 21705620
[TBL] [Abstract][Full Text] [Related]
65. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1.
La S; Kim E; Kwon B
Exp Mol Med; 2005 Jun; 37(3):193-8. PubMed ID: 16000873
[TBL] [Abstract][Full Text] [Related]
66. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
Lu L; Xu X; Zhang B; Zhang R; Ji H; Wang X
J Transl Med; 2014 Feb; 12():36. PubMed ID: 24502656
[TBL] [Abstract][Full Text] [Related]
67. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
[TBL] [Abstract][Full Text] [Related]
68. Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors.
Zhou P; L'italien L; Hodges D; Schebye XM
J Immunol; 2007 Dec; 179(11):7365-75. PubMed ID: 18025180
[TBL] [Abstract][Full Text] [Related]
69. Biological role of GITR/GITRL in attributes and immune responses of macrophage.
Fu Z; Wang S; Li J; Zhang Y; Li H; Li G; Wan X; Zhang Y
J Leukoc Biol; 2020 Feb; 107(2):309-321. PubMed ID: 31833599
[TBL] [Abstract][Full Text] [Related]
70. GITR: a modulator of immune response and inflammation.
Nocentini G; Riccardi C
Adv Exp Med Biol; 2009; 647():156-73. PubMed ID: 19760073
[TBL] [Abstract][Full Text] [Related]
71. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody.
Zhou P; Qiu J; L'Italien L; Gu D; Hodges D; Chao CC; Schebye XM
J Immunother; 2010 Oct; 33(8):789-97. PubMed ID: 20842058
[TBL] [Abstract][Full Text] [Related]
72. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
[TBL] [Abstract][Full Text] [Related]
73. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
Mahne AE; Mauze S; Joyce-Shaikh B; Xia J; Bowman EP; Beebe AM; Cua DJ; Jain R
Cancer Res; 2017 Mar; 77(5):1108-1118. PubMed ID: 28122327
[TBL] [Abstract][Full Text] [Related]
74. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
[TBL] [Abstract][Full Text] [Related]
75. RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1.
Burren S; Reche K; Blank A; Galvàn JA; Dawson H; Berger MD; Zlobec I; Lugli A
Pathol Res Pract; 2021 Jul; 223():153486. PubMed ID: 34051513
[TBL] [Abstract][Full Text] [Related]
76. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
Qin JZ; Upadhyay V; Prabhakar B; Maker AV
J Transl Med; 2013 Mar; 11():70. PubMed ID: 23514280
[TBL] [Abstract][Full Text] [Related]
77. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
[TBL] [Abstract][Full Text] [Related]
78. B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.
Moore TC; Gonzaga LM; Mather JM; Messer RJ; Hasenkrug KJ
mBio; 2017 Aug; 8(4):. PubMed ID: 28765225
[TBL] [Abstract][Full Text] [Related]
79. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
80. Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation.
Zhao M; Fu L; Chai Y; Sun M; Li Y; Wang S; Qi J; Zeng B; Kang L; Gao GF; Tan S
Cell Rep; 2021 Sep; 36(12):109734. PubMed ID: 34551288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
